Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Influenza A Virus”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Early research (Phase 1)WithdrawnNCT01676675
What this trial is testing

A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults

Who this might be right for
Healthy
Jiangsu Province Centers for Disease Control and Prevention
Testing effectiveness (Phase 2)Study completedNCT02691130
What this trial is testing

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 224
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT01910519
What this trial is testing

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00984945
What this trial is testing

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 48
Early research (Phase 1)Study completedNCT01317745
What this trial is testing

H5N1 Mix and Match With MF59

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 270
Testing effectiveness (Phase 2)Study completedNCT01938742
What this trial is testing

H7N9 Mix and Match With MF59 in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 700
Not applicableWithdrawnNCT00417560
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses

Who this might be right for
Influenza
Centers for Disease Control and Prevention
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00519389
What this trial is testing

Safety, Reactogenicity and Immunogenicity of an H5N1 VLP

Who this might be right for
Pandemic Influenza
Novavax 230
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT01788228
What this trial is testing

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT00734175
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Study completedNCT01776554
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 662
Testing effectiveness (Phase 2)Study completedNCT00298233
What this trial is testing

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Who this might be right for
InfluenzaAvian InfluenzaSevere Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 326
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Not applicableStudy completedNCT00428753
What this trial is testing

China Case Control Avian Influenza

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Load More Results